Intrinsic Value of S&P & Nasdaq Contact Us

Amplia Therapeutics Limited INNMF OTC

Other OTC • Healthcare • Biotechnology • AU • USD

SharesGrow Score
32/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — INNMF

Amplia Therapeutics Limited (INNMF) has a market capitalization of $47.2M and trades at $0.09. The 52-week range is 0.029-0.272.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -4.3, Earnings Per Share (EPS) of $-0.02, annual revenue of $3.78M.

The stock has a beta of -0.21, operates in the Healthcare sector.

Trading Data
Current Price$0.09
52-Week Range0.029-0.272
Volume7.5K
Avg Volume (30D)10.62K
Market Cap$47.2M
Beta (1Y)-0.21
Company
IPO Date2021-01-08
CEOChristopher J. Burns
CountryAU
ExchangeOther OTC
CurrencyUSD
ISINAU0000023822
Income (Latest Year)
Revenue$3.78M
Gross Profit$3.57M
EBITDA$-6.78M
Operating Income$-6.52M
Net Income$-6.57M
EPS$-0.02
EPS Diluted$-0.02
Shares Outstanding$307.1M
Balance Sheet (Latest Year)
Total Assets$22.94M
Current Assets$14.93M
Cash & ST Investments$10.86M
Total Liabilities$1.91M
Total Debt$13.89K
Net Debt$-10.85M
Total Equity$21.02M
Debt / Equity0.00
Valuation Ratios
P/E Ratio-4.3
P/S Ratio12.48
P/B Ratio2.25
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message